← Brewed Up Insight No. 2

RPG pays up to ₹135 crore, 7x sales, for an approved API plant

Raghava Life Sciences’ API business did about ₹19 crore in FY26. What RPG is buying is the approval: WHO GMP and EU GMP, ~300 kl of capacity and 29 molecules.

RPG pays up to ₹135 crore, 7x sales, for an approved API plant

Raghava Life Sciences’ API business did about ₹19 crore in FY26. What RPG is buying is the approval: WHO GMP and EU GMP, ~300 kl of capacity and 29 molecules.

₹ CRORE

Raghava API revenue, FY2619
RPG pays, up to135
Plant at full use, management estimate200
RPG Life Sciences pays up to ₹135 crore, 7x sales, for Raghava's approved API plant, which did ₹19 crore in FY26.

7.1x FY26 sales, for a plant near Hyderabad

The plant’s ₹200 crore potential is a management estimate reported in the press, not a filed figure. ₹135 crore is a ceiling, subject to adjustments.

RPG Life Sciences, BSE filing of 29 July 2026 · FY26

Share it

The numbers

Embed it on your site

The code carries a credit line that links back to this page. Keep it with the chart.

Get in touch